{"nct_id":"NCT01814800","title":"Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)","status":"COMPLETED","status_verified_date":"2016-08","start_date":"2014-02","start_date_type":null,"primary_completion_date":"2014-12","primary_completion_date_type":"ACTUAL","completion_date":"2015-01","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ADMA"]}